GO
Loading...

Enter multiple symbols separated by commas

Hedge Funds Carl Icahn

More

  • Qwest Long Distance Business Gets Disappointing Bids Thursday, 4 Jun 2009 | 5:33 PM ET
    Qwest's company headquarters in Denver, Colorado.

    Initial bids for Qwest Communications' long-distance business are below the $2 billion to $3 billion the telecommunications company sought, The Wall Street Journal reported Thursday.

  • Three Down, One To Go Thursday, 4 Jun 2009 | 2:34 PM ET
    Amylin

    In less than two weeks, there've been four pretty significant events in biopharma. And, hopefully, after ADA things will begin to settle down a bit for the summer.

  • Pharmaceuticals' Price, Politics & Proxies Tuesday, 2 Jun 2009 | 3:41 PM ET
    pharma_new3.jpg

    The cost of drugs was a hot topic at ASCO this year, especially with the release of the big test results combining two very expensive treatments for lung cancer. The study showed using Avastin from Roche and Genentech and a pill, Tarceva, from OSI Pharmaceuticals, Roche and Genentech slowed down progression of the disease by a little more than a month.

  • Kudlow: US Now Owns GM, But Won't Get Paid Back Friday, 29 May 2009 | 6:34 PM ET

    Get ready folks: America is about to own a car company. As of Monday, we the taxpayers will own more than 70 percent of GM. Whether the company will be formally renamed Government Motors remains to be seen. But that’s what it will be.

  • Amylin & Biogen Idec Activists, ASCO & ADA Thursday, 21 May 2009 | 12:49 PM ET
    Amylin

    It's going to be a crazy busy, stressful couple of weeks. A shareholder meeting, a medical meeting, then another shareholder meeting and finally another medical meeting.

  • There's No ME in aMYlin Monday, 11 May 2009 | 10:19 AM ET
    Amylin

    Imagine my surprise when I got an email over the weekend from "Diabetic Investor" newsletter editor David Kliff informing me that Amylin Pharmaceuticals is quoting me in a letter to shareholders.

  • The ABC's of Lilly: Amylin, Byetta & Carl Monday, 20 Apr 2009 | 11:39 AM ET
    Byetta Needle

    Shortly after Eli Lilly reported way better than expected earnings this morning, Amylin Pharmaceuticals fired a new salvo in its escalating proxy battle with billionaire activist investor Carl Icahn.

  • Carl Icahn Answers Your Questions Wednesday, 8 Apr 2009 | 6:58 PM ET
    graphic_fast_money.jpg

    Wondering if Carl Icahn is bullish or bearish on stocks right now? Find out!

  • Exclusive Interview with Carl Icahn Wednesday, 8 Apr 2009 | 6:51 PM ET
    graphic_fast_money.jpg

    Once again, activist investor Carl Icahn turns to Fast Money to set the record straight on all the rumors surrounding his wheeling and dealing.

  • Facing Recession And Carl Icahn: Lionsgate Cuts Jobs Friday, 27 Mar 2009 | 4:35 PM ET

    Being an independent studio rather than part of a media conglomerate, isn't helping Lionsgate avoid pink slips. The movie studio announced Friday that it's cutting 45 jobs.

  • Amylin In North Dakota? You Betcha Monday, 2 Feb 2009 | 1:37 PM ET
    Amylin

    Diabetes drugmaker Amylin Pharmaceuticals is headquartered in San Diego. Like a lot of companies, though, it's incorporated in Delaware. But, if a couple of major shareholders get their way, AMLN could reincorporate in an unlikely state.

  • EXCLUSIVE: Web Extra -  Icahn On Private Equity Monday, 3 Nov 2008 | 7:17 PM ET
    webxtra_thumb.jpg

    Billions in loans were extended to private equity. How deep in the weeds are they? "In many cases they're buried," Icahn tells us in a Web Extra exclusive.

  • Final Thoughts On Tuesday's Election Monday, 3 Nov 2008 | 7:05 PM ET
    graphic_final_trade.jpg

    Here’s our Fast Money Final Trade. Instead of stock picks our gang gives you their thoughts on the brave new world that comes after the election.

  • Carl’s Corner: The Election Monday, 3 Nov 2008 | 6:49 PM ET
    graphic_fast_money.jpg

    Ahead of the election, you should know Carl Icahn has a few concerns.

  • Carl’s Corner Pt. 1: CEO Compensation Monday, 3 Nov 2008 | 6:44 PM ET
    graphic_fast_money.jpg

    Carl Icahn might be a lot of things, but shy isn’t one of them. If there’s something he doesn’t like, expect to hear about. And there’s something he doesn’t like.

  • Lions Gate Vice Chair Forced to Sell Shares Wednesday, 22 Oct 2008 | 9:24 AM ET
    lions_gate_logo.jpg

    Carl Icahn's recent increased investment in Lions Gate shares isn't the only news resulting from the company's low stock price. On October 10 the stock dipped below $6, triggering a margin call by Merrill Lynch for Vice Chairman Michael Burns, selling 672,000 shares of his stock, 49 percent of his stake in the company, recorded in a Form 4 filed on October 14.

  • Your First Move For Thursday October 16th Wednesday, 15 Oct 2008 | 7:08 PM ET
    graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Carl’s Corner Pt 1: One Aggravated Billionaire Wednesday, 15 Oct 2008 | 6:58 PM ET
    graphic_fast_money.jpg

    If there’s one billionaire investor you don’t want to aggravate its Carl Icahn. What makes us say that? He’s aggravated. Really aggravated. Wait till you see what’s got him going.

  • Carl's Corner Pt. 3: Riding In His Wake Wednesday, 15 Oct 2008 | 6:58 PM ET
    graphic_fast_money.jpg

    We couldn’t talk with legendary investor Carl Icahn and not ask about his portfolio. Here’s what’s got his attention these days.

  • Icahn: Back Room Deals Must End! Monday, 6 Oct 2008 | 6:30 PM ET
    graphic_fast_money.jpg

    Fed up with the back room wheeling and dealing on Wall Street? Now you can do something about it, thanks to Carl Icahn.